Effects of calmodulin-dependent protein kinase II inhibitor, KN-93, on electrophysiological features of rabbit hypertrophic cardiac myocytes

Abstract

Cardiac hypertrophy is an independent risk factor for sudden cardiac death in clinical settings and the incidence of sudden cardiac death and ventricular arrhythmias are closely related. The aim of this study was to determine the effects of the calmodulin-dependent protein kinase (CaMK) II inhibitor, KN-93, on L-type calcium current (I_{Ca, L}) and early after-depolarizations (EADs) in hypertrophic cardiomyocytes. A rabbit model of myocardial hypertrophy was constructed through abdominal aortic coarctation (LVH group). The control group (sham group) received a sham operation, in which the abdominal aortic was dissected but not coarcted. Eight weeks later, the degree of left ventricular hypertrophy (LVH) was evaluated using echocardiography. Individual cardiomyocyte was isolated through collagenase digestion. Action potentials (APs) and I_{Ca, L} were recorded using the perforated patch clamp technique. APs were recorded under current clamp conditions and I_{Ca, L} was recorded under voltage clamp conditions. The incidence of EADs and I_{ca, L} in the hypertrophic cardiomyocytes were observed under the conditions of low potassium (2 mmol/L), low magnesium (0.25 mmol/L) Tyrode’s solution perfusion, and slow frequency (0.25–0.5 Hz) electrical stimulation. The incidence of EADs and I_{ca, L} in the hypertrophic cardiomyocytes were also evaluated after treatment with different concentrations of KN-92 (KN-92 group) and KN-93 (KN-93 group). Eight weeks later, the model was successfully established. Under the conditions of low potassium, low magnesium Tyrode’s solution perfusion, and slow frequency electrical stimulation, the incidence of EADs was 0/12, 11/12, 10/12, and 5/12 in sham group, LVH group, KN-92 group (0.5 μmol/L), and KN-93 group (0.5 μmol/L), respectively. When the drug concentration was increased to 1 μmol/L in KN-92 group and KN-93 group, the incidence of EADs was 10/12 and 2/12, respectively. At 0 mV, the current density was 6.7±1.0 and 6.3±0.7 PA·PF⁻¹ in LVH group and sham group, respectively (P>0.05, n=12). When the drug concentration was 0.5 μmol/L in KN-92 and KN-93 groups, the peak I_{Ca, L} at 0 mV was decreased by (9.4±2.8)% and (10.5±3.0)% in the hypertrophic cardiomyocytes of the two groups, respectively (P>0.05, n=12). When the drug concentration was increased to 1 μmol/L, the peak I_{Ca, L} values were lowered by (13.4±3.7)% and (40±4.9)%, respectively (P<0.01, n=12). KN-93, a specific inhibitor of CaMKII, can effectively inhibit the occurrence of EADs in hypertrophic cardiomyocytes partially by suppressing I_{Ca, L}, which may be the main action mechanism of KN-93 antagonizing the occurrence of ventricular arrhythmias in hypertrophic myocardium.

Keywords

calmodulin-dependent protein kinase II / KN-93 / myocardial hypertrophy / electrophysiology / perforated patch recording techniques

References

[1] ZhangT., BrownJ.H.. Role of Ca²⁺/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res, 2004, 63(3): 476-486

[2] AndersonM.E.. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther, 2005, 106(1): 39-55

[3] LiY., MaJ., XiaoJ.M., et al.. Heterogeneity of action potential and ion currents in the left ventricular myocytes of the rabbit. Acta Physiologica Sinica, 2002, 54(5): 369-374

[4] GillisA.M., GeonzonR.A., MathisonH.J., et al.. The effects of barium, dofetilide and 4-aminopyndine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart. J Pharmacol Exp Ther, 1998, 285(1): 262-270

[5] JafaryF.H.. Devereux formula for left ventricular mass-be careful to use the right units of measurement. J Am Soc Echocardiogr, 2007, 20(6): 783-791

[6] FuL.Y., WangF., ChenX.S., et al.. Perforated patch recording of L-type calcium current with β-escin in guinea pig ventricular myocytes. Acta Pharmacol Sin, 2003, 24(11): 1094-1098

[7] FanJ.S., PaladeP.. Perforated patch recording with beta-escin. Pflügers Arch, 1998, 436(6): 1021-1023

[8] SalaM., CoppaF., CappucciatiC., et al.. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr Opin Investig Drugs, 2006, 7(3): 256-263

[9] TanskanenA.J., GreensteinJ.L., O’RourkeB., et al.. The role of stochastic and modal gating of cardiac L-type Ca²⁺ channels on early after-depolarizations. Biophys J, 2005, 88(1): 85-95

[10] ThomasG., GurungI.S., KilleenM.J., et al.. Effects of L-type Ca²⁺ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome. J Physiol, 2007, 578Pt1: 85-97

[11] QiX., YehY.H., ChartierD., et al.. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome. Circ Arrhythm Electrophysiol, 2009, 2(3): 295-304

[12] AndersonM.E.. QT interval prolongation and arrhythmia: an unbreakable connection?. J Intern Med, 2006, 259(1): 81-90

[13] WuY., TempleJ., ZhangR., et al.. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation, 2002, 106(10): 1288-1293

[14] AndersonM.E.. Calmodulin kinase and L-type calcium channels: A recipe for arrhythmias?. Trends Cardiovasc Med, 2004, 14(4): 152-161

[15] AiX., CurranJ.W., ShannonT.R., et al.. Ca²⁺/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca²⁺ leak in heart failure. Circ Res, 2005, 97(12): 1314-1322